Metagenomi Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.54

+0.13 (+9.22%)

As of Feb 8, 2:17 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +1,887.0% upside

Low Target $21.05

Average Target $30.60

High Target $40.98

Current Price $1.54

Current
$1.54

Target
$30.60

$21.05 $30.60 avg $40.98

Scenario Analysis

Bear Case

$21.05

1,266.9%

Low target

Base Case

$30.60

+1,887.0%

Avg target

Bull Case

$40.98

+2,561.0%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$25.54

-94.0% from high

52-Week Low

$13.60

+-88.7% from low

Target vs 52W High

$30.60

+19.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%